Source: ALL
Variant Gene Disease Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs965469
rs965469
Entrez Id: 25943
Gene Symbol: C20orf194
C20orf194
CUI: C0524910
Disease:
Hepatitis C, Chronic 		0.800 GeneticVariation GWASCAT Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients. 21703177 2012
dbSNP: rs965469
rs965469
Entrez Id: 25943
Gene Symbol: C20orf194
C20orf194
CUI: C0524910
Disease:
Hepatitis C, Chronic 		0.800 GeneticVariation GWASDB Genome-wide association study of interferon-related cytopenia in chronic hepatitis C patients. 21703177 2012
dbSNP: rs2007022
rs2007022
Entrez Id: 25943
Gene Symbol: C20orf194
C20orf194
CUI: C0005890
Disease:
Body Height 		0.700 GeneticVariation GWASCAT Leveraging Polygenic Functional Enrichment to Improve GWAS Power. 30595370 2019
dbSNP: rs6051761
rs6051761
Entrez Id: 25943
Gene Symbol: C20orf194
C20orf194
CUI: C0200635
Disease:
Lymphocyte Count measurement 		0.700 GeneticVariation GWASDB The combination of a genome-wide association study of lymphocyte count and analysis of gene expression data reveals novel asthma candidate genes. 22286170 2012
dbSNP: rs6051702
rs6051702
Entrez Id: 25943
Gene Symbol: C20orf194
C20orf194
CUI: C0002871
Disease:
Anemia 		0.040 GeneticVariation BEFREE Polymorphisms of inosine triphosphate pyrophosphatase (rs1127354 and rs6051702) and interferon lambda 4 (IFLN4) (rs12979860) are indicators of anemia and/or sustained virological response (SVR) in patients with chronic hepatitis C on ribavirin/interferon. 31359493 2020
dbSNP: rs6051702
rs6051702
Entrez Id: 25943
Gene Symbol: C20orf194
C20orf194
CUI: C0002871
Disease:
Anemia 		0.040 GeneticVariation BEFREE Baseline testing of rs6051702 may identify the subset of patients at greatest risk for RBV-induced anaemia using interferon-free hepatitis C therapies. 28198349 2017
dbSNP: rs6051702
rs6051702
Entrez Id: 25943
Gene Symbol: C20orf194
C20orf194
CUI: C0002871
Disease:
Anemia 		0.040 GeneticVariation BEFREE The ITPA rs1127354 CC and rs6051702 AA genotypes may predict ribavirin-induced anemia during treatment with interferon-free, ribavirin-containing regimens. 26650626 2015
dbSNP: rs6051702
rs6051702
Entrez Id: 25943
Gene Symbol: C20orf194
C20orf194
CUI: C0002871
Disease:
Anemia 		0.040 GeneticVariation BEFREE In multivariate logistic regression analyses the carrier of a variant allele in the rs6051702/rs1127354 association (OR=0.11, p=1.75×10(-5)) and Hb at baseline (OR=1.51, p=1.21×10(-4)) were independently associated with protection against clinically significant anemia at week 4. 23933495 2013
dbSNP: rs6051702
rs6051702
Entrez Id: 25943
Gene Symbol: C20orf194
C20orf194
CUI: C0524910
Disease:
Hepatitis C, Chronic 		0.010 GeneticVariation BEFREE Polymorphisms of inosine triphosphate pyrophosphatase (rs1127354 and rs6051702) and interferon lambda 4 (IFLN4) (rs12979860) are indicators of anemia and/or sustained virological response (SVR) in patients with chronic hepatitis C on ribavirin/interferon. 31359493 2020
dbSNP: rs6051702
rs6051702
Entrez Id: 25943
Gene Symbol: C20orf194
C20orf194
CUI: C0019196
Disease:
Hepatitis C 		0.010 GeneticVariation BEFREE Baseline testing of rs6051702 may identify the subset of patients at greatest risk for RBV-induced anaemia using interferon-free hepatitis C therapies. 28198349 2017
dbSNP: rs149767043
rs149767043
Entrez Id: 25943
Gene Symbol: C20orf194
C20orf194
CUI: C0018790
Disease:
Cardiac Arrest 		0.010 GeneticVariation BEFREE The expansion showed complete segregation with the SCA phenotype in family studies, whereas Phe265Leu in C20orf194 did not. 21683323 2011